Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID)

Annals of Intensive Care

Table 3 Outcomes in the groups with vs. without COVID-19-associated pulmonary aspergillosis according to 2020 ECMM/ISHAM consensus criteria

	All patients (n = 708)	Probable CAPA (n = 18)	No CAPA (n = 690)
Day-90 mortality, n (%)	202 (28.5)	10 (55.6)	192 (27.8)
MV duration, days, median [IQR]	15.0 [8.00–27.00]	27.0 [18.00–34.00]	15.0 [8.00–26.00]
ICU length of stay, days, median [IQR]	19.0 [11.00–31.00]	26.5 [19.00–54.00]	19.0 [11.00–31.00]

Outcomes were available for all patients included in the study
CAPA COVID-19-associated pulmonary aspergillosis, 95% CI 95% confidence interval, MV endotracheal mechanical ventilation, ICU intensive care unit